Objective:To study the effects of continue subcutaneous insulin injection(CSII) in newly diagnosed type 2 diabetic patients with insulin pump.
目的探讨胰岛素泵持续皮下注射胰岛素在早发2型糖尿病患者治疗的疗效。
Conclusion Multifactorial intensive treatment may improve the metabolic syndrome of newly diagnosed type 2 diabetic patients, but the improvement on central obesity and HDL-C is limited.
结论多因素的强化治疗可显著改善2型糖尿病患者的代谢综合征，但以目前的治疗措施，针对中心性肥胖和HDL C的改善作用有限。
The purpose of this study was to evaluate the effect of short-term continuously subcutaneous insulin infusion (CSII) combined with Rosiglitazone on newly diagnosed type 2 diabetic patients.
本研究的目的是CSII联合文迪雅强化治疗初诊2型糖尿病以评价其临床疗效。
应用推荐